What we have learned about Lyme borreliosis from studies in children

Wien Klin Wochenschr. 2006 Nov;118(21-22):638-42. doi: 10.1007/s00508-006-0689-8.

Abstract

Although pediatric Lyme borreliosis (LB) need not be a separate nosological entity, there are clinically important differences in presentation, antibiotic regimens and outcomes in children, which provide lessons that can be extrapolated to the disease as it affects adults. A large proportion of the worldwide data is obtained from children. The aim of this presentation is not to present an exhaustive review of the pediatric literature, but to review a selection of pediatric studies that have made a significant contribution to our body of knowledge in Lyme borreliosis.

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Amoxicillin / administration & dosage
  • Amoxicillin / therapeutic use
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use
  • Borrelia burgdorferi* / immunology
  • Cefuroxime / administration & dosage
  • Cefuroxime / therapeutic use
  • Child
  • Child, Preschool
  • Clinical Trials as Topic
  • Diagnosis, Differential
  • Erythema Chronicum Migrans / diagnosis
  • Follow-Up Studies
  • Humans
  • Immunoblotting
  • Infant
  • Lyme Disease Vaccines / administration & dosage
  • Lyme Disease Vaccines / immunology
  • Lyme Disease* / diagnosis
  • Lyme Disease* / drug therapy
  • Lyme Disease* / immunology
  • Lyme Neuroborreliosis / complications
  • Lyme Neuroborreliosis / diagnosis
  • Multicenter Studies as Topic
  • Prospective Studies
  • Time Factors
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Lyme Disease Vaccines
  • Amoxicillin
  • Cefuroxime